Clinical importance of ADAMTS13 activity during remission in patients with acquired thrombotic thrombocytopenic purpura.
Department of Biostatistics and Epidemiology, College of Public Health, and Hematology-Oncology Section, Department of Medicine, College of Medicine, The University of Oklahoma Health Sciences Center, Oklahoma City, OK.
Evaren E
EE
Page
Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, Bern, Switzerland; and Department of Clinical Research, University of Bern, Bern, Switzerland.
Johanna A
0000-0002-1300-7135
JA
Kremer Hovinga
Department of Biostatistics and Epidemiology, College of Public Health, and.
Deirdra R
DR
Terrell
Department of Biostatistics and Epidemiology, College of Public Health, and.
Sara K
0000-0003-3448-0156
SK
Vesely
Department of Biostatistics and Epidemiology, College of Public Health, and Hematology-Oncology Section, Department of Medicine, College of Medicine, The University of Oklahoma Health Sciences Center, Oklahoma City, OK.
James N
JN
George
D000071120:ADAMTS13 Protein / Q000276:immunology* / Q000378:metabolism*; D001323:Autoantibodies / Q000097:blood*; D015415:Biomarkers / Q000097:blood; D015331:Cohort Studies; D006801:Humans; D011237:Predictive Value of Tests; D011379:Prognosis; D011697:Purpura, Thrombotic Thrombocytopenic / Q000175:diagnosis* / Q000276:immunology / Q000378:metabolism; D012008:Recurrence; D012075:Remission, Spontaneous
D001323:Autoantibodies; D015415:Biomarkers; D000071120:ADAMTS13 Protein; C099604:ADAMTS13 protein, human